Search results

From September 2026 newly qualified pharmacists will enter the General Pharmaceutical Council register as independent prescribers. There are also many training and education initiatives funded through the NHS England Pharmacy Integration Fund that…

Secondary Care Medicines Data (SCMD) is published by the NHSBSA on behalf of NHS England. It contains processed pharmacy stock control data in a standardised format from all NHS Acute, Teaching, Specialist, Mental Health, and Community Trusts in…

Misinterpreting active community pharmacies We have been made aware that our headline figure for active community pharmacies can be misinterpreted. We would like to draw your attention to some important information for this figure. When a…

Reimbursement and remuneration based data are collected by NHS Prescription Services. The data relates to the total NHS prescriptions dispensed or personally administered in England.  PD1 reports show these in a particular month by each dispenser…

This is an announcement on behalf of the Department of Health and Social Care: ESPAUR identified that they sent out an erroneous email last week to certain pharmacy contractors. This email was sent to contractors who, according to ESPAUR’s records…

The NHSBSA data services team has used the open data portal to publish the latest 2023/24 Pharmacy Quality Scheme (PQS) data. This dataset is publicly available, and you can explore it on the open data portal website. Part of the Community Pharmacy…

These charts are updated each month and show up to five years' data. They show the: number and cost of items number of items declared by pharmacy contractors Number of items declared by pharmacy contractors in England At the end of each…

Monthly information on the number of flu vaccines administered by pharmacy contractors under the community pharmacy seasonal influenza vaccination advanced service. Advance Service Flu Report – Pharmacy Contractors The report is available to…

This pilot will evaluate the implementation of direct referrals by Community Pharmacy to secondary care for people with suspected cancer signs and symptoms. It will start by focusing on testing safety and technical feasibility with a small number of…